QUICKLINKS FOR Metropolis Healthcare Ltd

Metropolis Healthcare Ltd Peer Comparison - Competitive Analysis

NSEBSE

₹1,914

(-0.44%)

Dec 12, 2025|12:00:00 AM

Invest wise with Expert advice

METROPOLIS HEALTHCARE LTD PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Max Healthcare Institute Ltd MAXHEALTH	1,081.3	151.64	1,05,175.82	160.42	0.14	736.62	87.33
Apollo Hospitals Enterprise Ltd APOLLOHOSP	7,101	72.85	1,02,112.99	419.9	0.18	2,356.1	647.83
Fortis Healthcare Ltd FORTIS	874.05	356.86	66,005.99	125.09	0.11	455.81	121.53
Narayana Hrudayalaya Ltd NH	1,870.2	82.29	38,222.62	137.88	0.24	1,019.17	113.49
Aster DM Healthcare Ltd ASTERDM	620.35	95.15	32,144.23	104.61	0.78	681.81	84.55

Metropolis Healt: RELATED NEWS

Metropolis Healthcare Acquires Ambika Pathology for ₹17 Crore; Stock Rises 2.85%

The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.

19 Sep 2025|11:10 AM

Metropolis Healthcare Reports 19% Drop in Q4 Net Profit

The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.

14 May 2025|10:59 AM

Metropolis Healthcare Q3 Profit Rises 15.4% to ₹31.4 Crore

The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.

6 Feb 2025|10:11 AM

Metropolis Acquires Core Diagnostics for ₹247 Crore to Boost Cancer Testing Expertise

This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.

10 Dec 2024|04:16 PM